What is behind the fall of Inovio Pharmaceuticals Inc. (INO) stock?
Inovio Pharmaceuticals Inc. (INO), a biotechnology company that focuses on the discovery, development, and commercialization of precisely designed DNA medicines to treat and protect people from infectious diseases, announced its plan for phase 3 trial of its COVID-19 vaccine candidate, INO-4800. In accordance to the rapid production of various vaccines, the Defense Health Agency (DHA) […]
